# TACE for HCC by TANDEM and Idarubicin

> **NCT03349957** · — · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 98 (actual)

## Conditions studied

- Hepatocellular Carcinoma (HCC)

## Interventions

- **DRUG:** Transarterial chemoembolization using TANDEM and idarubicin

## Key facts

- **NCT ID:** NCT03349957
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-01
- **Primary completion:** 2018-01-30
- **Final completion:** 2018-03-30
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2018-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03349957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03349957, "TACE for HCC by TANDEM and Idarubicin". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03349957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*